Novel immunotherapy mechanism suppresses breast cancer development (IMAGE)

Massachusetts General Hospital

Novel immunotherapy mechanism suppresses breast cancer development

Caption

New research from Massachusetts General Hospital describes how CD4+ T cells activated by an immune factor called thymic stromal lymphopoietin suppress breast cancer by differentiating cancer into benign cyst-like structures. Here, T cells (yellow) are inducing cyst formation in breast cancer (green), which prevents the cancer cells from proliferating (Ki67 as the marker of cell proliferation, red).

Credit

Emanuela Marchese, PhD

Usage Restrictions

Please ask permission.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.